Details for New Drug Application (NDA): 085461
✉ Email this page to a colleague
NDA 085461 describes LIBRIUM, which is a drug marketed by Bausch and Valeant Pharm Intl and is included in five NDAs. It is available from three suppliers. Additional details are available on the LIBRIUM profile page.
The generic ingredient in LIBRIUM is chlordiazepoxide hydrochloride. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride profile page.
The generic ingredient in LIBRIUM is chlordiazepoxide hydrochloride. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride profile page.
Summary for 085461
| Tradename: | LIBRIUM |
| Applicant: | Valeant Pharm Intl |
| Ingredient: | chlordiazepoxide hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 085461
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LIBRIUM | chlordiazepoxide hydrochloride | CAPSULE;ORAL | 085461 | ANDA | Epic Pharma, LLC | 42806-564 | 42806-564-01 | 100 CAPSULE, GELATIN COATED in 1 BOTTLE (42806-564-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
